A computational model of the hypothalamic - pituitary - gonadal axis in female fathead minnows (Pimephales promelas) exposed to 17α-ethynylestradiol and 17β-trenbolone by Li, Zhenhong et al.
RESEARCH ARTICLE Open Access
A computational model of the hypothalamic -
pituitary - gonadal axis in female fathead
minnows (Pimephales promelas) exposed to
17a-ethynylestradiol and 17b-trenbolone
Zhenhong Li
1, Kevin J Kroll
2, Kathleen M Jensen
3, Daniel L Villeneuve
3, Gerald T Ankley
3, Jayne V Brian
4,
María S Sepúlveda
5, Edward F Orlando
6, James M Lazorchak
7, Mitchell Kostich
7, Brandon Armstrong
8,
Nancy D Denslow
2 and Karen H Watanabe
1*
Abstract
Background: Endocrine disrupting chemicals (e.g., estrogens, androgens and their mimics) are known to affect
reproduction in fish. 17a-ethynylestradiol is a synthetic estrogen used in birth control pills. 17b-trenbolone is a
relatively stable metabolite of trenbolone acetate, a synthetic androgen used as a growth promoter in livestock.
Both 17a-ethynylestradiol and 17b-trenbolone have been found in the aquatic environment and affect fish
reproduction. In this study, we developed a physiologically-based computational model for female fathead
minnows (FHM, Pimephales promelas), a small fish species used in ecotoxicology, to simulate how estrogens (i.e.,
17a-ethynylestradiol) or androgens (i.e., 17b-trenbolone) affect reproductive endpoints such as plasma
concentrations of steroid hormones (e.g., 17b-estradiol and testosterone) and vitellogenin (a precursor to egg yolk
proteins).
Results: Using Markov Chain Monte Carlo simulations, the model was calibrated with data from unexposed, 17a-
ethynylestradiol-exposed, and 17b-trenbolone-exposed FHMs. Four Markov chains were simulated, and the chains
for each calibrated model parameter (26 in total) converged within 20,000 iterations. With the converged
parameter values, we evaluated the model’s predictive ability by simulating a variety of independent experimental
data. The model predictions agreed with the experimental data well.
Conclusions: The physiologically-based computational model represents the hypothalamic-pituitary-gonadal axis in
adult female FHM robustly. The model is useful to estimate how estrogens (e.g., 17a-ethynylestradiol) or androgens
(e.g., 17b-trenbolone) affect plasma concentrations of 17b-estradiol, testosterone and vitellogenin, which are
important determinants of fecundity in fish.
Background
In vertebrates, such as fish, the hypothalamic-pituitary-
gonadal (HPG) axis controls reproductive processes
through a variety of hormones which act on target tis-
sues directly or indirectly [1,2]. The HPG axis can be
altered by endocrine disrupting chemicals (EDCs) in
the aquatic environment which mimic endogenous
hormones, alter their concentrations, or block their
actions [3].
In recent years, many scientific studies have been con-
ducted to study reproductive effects of EDCs in fathead
minnow (FHM, Pimephales promelas), a model small
fish species used in ecotoxicology [4-6]. Two EDCs,
17a-ethynylestradiol and 17b-trenbolone, have been
widely studied as model estrogens and androgens,
respectively [7-11]. Both compounds also are environ-
mentally relevant contaminants. * Correspondence: watanabe@ebs.ogi.edu
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any medium, provided the original work is properly cited.17a-ethynylestradiol (EE2), a synthetic estrogen used
in birth control pills, enters the environment mainly
through effluents from wastewater treatment facilities.
The reported median EE2 concentration in the aquatic
environment varies from <0.5 to 15 ng/L [12]. Due in
part to its high binding affinity for estrogen receptor
(ER) [13-15], EE2 affects the HPG axis in FHM at envir-
onmentally relevant concentrations. Exposure to EE2 has
been shown to result in altered hormone profiles, and
increased vitellogenin (VTG, a precursor of egg yolk
proteins) levels in both male and female FHMs [16]. In
addition, a seven-year, whole-lake experiment conducted
in Canada [17] showed that chronic exposure of FHMs
to 5 - 6 ng EE2/L led to near-extinction of this species
from the lake.
17b-trenbolone (TB) is a relatively stable metabolic
product of trenbolone acetate, a synthetic androgen
used as a growth promoter in livestock (e.g., cattle). TB
enters the environment mainly as runoff from livestock
feedlots. Schiffer et al. [18] reported that the TB concen-
tration in effluents of solid cattle dung was around 19
ng/L. Durhan et al. [19] studied a cattle feedlot located
in southwest central Ohio, and reported that the TB
concentration in feedlot discharge was between 10 and
20 ng/L. TB has a high binding affinity for the androgen
receptor (AR). Water exposure to TB at concentrations
similar to those found in the environment decreases egg
production in FHM in conjunction with changes in
plasma concentrations of 17b-estradiol (E2), testosterone
(T), and VTG in females [7]. Interestingly, relationships
between TB water exposure concentrations and plasma
E2, T and VTG concentrations were not monotonic, but
were “U-shaped” [7].
To better understand the dynamics of the HPG axis in
female FHMs and to facilitate the evaluation of adverse
outcomes on reproduction from both estrogenic and
androgenic EDC exposure, we developed a physiologi-
cally based computational model to simulate key repro-
ductive endpoints, such as plasma concentrations of E2,
T, and VTG, in adult female FHMs. The model simu-
lates absorption, distribution, and elimination of TB and
EE2 by incorporating salient physiological characteristics
of FHMs and modelling biochemical pathways and reac-
tions mathematically. This model is a first step toward
predicting adverse outcomes on reproduction, which is
an important component of ecological risk assessment.
It robustly links TB and EE2 exposure to plasma steroid
hormone and VTG concentrations, which can then be
used to predict effects on fecundity. Though this model
does not simulate oocyte growth dynamics to predict
fecundity, it can be integrated with an oocyte growth
dynamics model to do so. To our knowledge, it is the
first physiologically based model capable of simulating
exposure to a mixture of an estrogen and an androgen.
Methods
Model Formulation
We developed the HPG axis model for female FHM by
modifying a computational model for male FHM
described by Watanabe et al. [20]. The model simulates
time continuously, but it does not have a seasonal com-
ponent. In the following, we mainly focus on the unique
formulations and/or assumptions in this model for
female FHMs.
The model for female FHMs contains six tissue com-
partments which represent organs or tissues important
for absorption, distribution, metabolism, and elimination
of exogenous and endogenous chemicals of interest
(Figure 1). The six compartments are gill, brain, gonad,
liver, venous blood and “other”. In the arterial blood,
the concentrations of both free and bound chemicals
are equal to those in the venous blood compartment,
u n l e s sac h e m i c a l ( s )e n t e r st h eb o d yt h r o u g haw a t e r
exposure. As a result, we did not count arterial blood as
an independent compartment. Based upon a mass bal-
ance for each chemical of interest, a set of coupled
ordinary differential equations were formulated in each
compartment following the principles of physiologically
based pharmacokinetic modeling. A detailed description
of the differential equations can be found in Additional
File 1: Differential equations used in the HPG axis
model.
In the brain, gonad, and liver compartments, we simu-
lated both ER and AR dynamics. The AR component
was not included in the model for male FHM published
by Watanabe et al. [20]. ER binds estrogens (e.g., E2 and
EE2), and bound ER affects the production of VTG. AR
binds androgens (e.g., T and TB), and subsequently reg-
ulates biochemical processes such as the production of
gonadotropins [21]. A general mathematical formulation
of ligand-receptor binding is shown in Equation 1.
d(CiR,jVj)
dt
= k1 iR,jCi,jCR,jVj − Kd iR,jk1 iR,jCiR,jVj (1)
where, CiR, j (nmol/L) is the concentration of com-
pound i ( e . g .T ,T B ,E 2 and EE2) bound to its receptor
in compartment j ( e . g .b r a i n ,l i v e r ,g o n a d ,a n dv e n o u s
blood) ; Vj (L) is the volume of compartment j; k1_iR, j
(L/nmol/hr) is the association rate constant of com-
pound i with its receptor in compartment j; Ci, j (nmol/
L) is the concentration of free compound i in compart-
ment j; CR, j (nmol/L) is the concentration of unbound
receptor of compound i in compartment j; Kd_iR, j
(nmol/L) is the equilibrium dissociation constant of
compound i with its receptor in compartment j.
Gill
In the gill compartment, we did not simulate any pro-
duction of proteins (e.g., VTG), hormones (e.g.,
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Page 2 of 22Figure 1 Conceptual model of the HPG axis in adult female FHMs. Tissues in adult female FHMs are categorized into six compartments: gill,
brain, gonad, liver, venous blood, and other. Each compartment is defined by volume, blood flow, and partition coefficient, and performs
multiple physiological functions.
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Page 3 of 22luteinizing hormone, LH), or hormone receptors (e.g, ER
and AR). ER mRNA is present in FHM gills, however,
we did not simulate ER in the gill compartment because
the gill expression of ER is very low compared to other
tissues [22]. We simulated the exposure of female FHMs
to TB and/or EE2 in water, and the gill compartment is
where the exogenous chemicals are absorbed. The con-
centration of each chemical in exposure water was
represented as a function of time. Then, equilibrium
partitioning was assumed, and the FHM arterial blood
concentration was calculated from the water concentra-
tion using an equilibrium partition coefficient assigned
for each chemical (Equation 2). In addition, we assumed
that the gill compartment did not accumulate any che-
mical(s).
CArti =
FWgil × Ci,H20 + Fcar × CVeni
FWgil
λi,bld
+ Fcar
(2)
where, CArti (nmol/L) is the concentration of exogen-
ous chemical i in arterial blood; FWgil (L/hr) is the volu-
metric flow rate of water through the gills; Ci,H 2 0
(nmol/L) is the concentration of exogenous chemical i
(e.g. TB and EE2) in exposure water as a function of
time; Fcar (L/hr) is cardiac output; and CVeni (nmol/L)
is the concentration of exogenous chemical i in venous
blood; li,b l dis the partition coefficient for exogenous
chemical i between blood and water. Partition coeffi-
cients are often determined experimentally, but when a
measured or model-estimated value is unavailable, we
calibrate it to fit the experimental data.
Brain
In the brain compartment, three key assumptions were
made: (i) the down-regulation of LH (gonadotropin II)
synthesis by bound AR [23,24]; (ii) the up-regulation of
LH synthesis by bound ER [25]; and (iii) the down-regu-
lation of AR synthesis by free androgens [26,27].
In the brain, androgens have a negative feedback on
the synthesis and release of gonadotropin releasing hor-
mone (GnRH) [23], which in turn controls the synthesis
of gonadotropins. To investigate how androgens may
regulate GnRH, we searched for an androgen response
element (ARE) in the promoter regions of gnrh
genes. Due to a lack of information on gene promoter
sequences in FHM, we conducted the search in zebra-
fish (Danio rerio), a cyprinid fish closely related to
FHM. We found that gnrh promoters contain several
ARE half sites (tgttct) [24]. Thus, we postulated that
androgens have a negative control on GnRH synthesis
mainly through bound AR. However, we did not have
any measurements of GnRH in FHM and GnRH was
not included in the model, so we formulated a down-
regulation of LH synthesis by bound AR in the model.
Second, we assumed an up-regulation of LH synthesis
by bound ER in the brain compartment. This assump-
tion was based upon observations of estrogen response
elements (EREs) in the promoter region of the lh gene
and reports of estrogen-stimulated LH production in
fish [25]. Equation 3 describes the LH production rate
in the brain compartment as a function of bound AR
and ER. In the equation, PLH, brn (nmol/hr) is the pro-
duction rate of LH in brain; Pb_LH, brn (nmol/hr) is the
background production rate of LH in brain, which was
formulated as a diurnal cycle; CER_bd, brn (nmol/L) is the
total concentration of bound ER in brain, which equals
the sum of E2-a n dE E 2- bound ER concentrations;
ru_LH, brn (nmol/L) is an induction factor for LH pro-
duction by bound ER; CAR_bd, brn (nmol/L) is the total
concentration of bound AR in brain, which equals the
sum of T- and TB- bound AR concentrations ; rd_LH,
brn (nmol/L) is a factor for inhibition of LH production
by bound AR.
PLH,brn = Pb LH,brn ×
1+
CER bd,brn
ρu LH,brn
1+
CAR bd,brn
ρd LH,brn
(3)
The brain compartment is also very important for the
regulation of AR production [26,27]. In mammals (e.g.
rats, mice, and human), AR mRNA in brain is down-
regulated by androgens, such as T and dihydrotesto-
sterone [26,27], though little is known about the
corresponding mechanisms. We searched for AREs in
the promoter region of the ar gene in zebrafish, but did
not find any match. Hence, we postulated that the
down-regulation of AR mRNA by androgens is asso-
ciated with a non-genomic pathway [28], or associated
with cell factors other than the soluble AR simulated in
our model [29]. Thus, we assumed a down-regulation of
AR production by free androgens in the brain compart-
ment. When ARs are produced, some bind androgens,
some remain unbound, and others degrade. Based upon
a mass balance for free AR, Equation 4 describes the
processes of AR production, association and dissociation
with T or TB, and degradation.
d(CAR free,brn)
dt
=
PbgAR,brn
1+
(CT,brn + CTB,brn)
KAR,brn
− (k1 TAR,brn × CT,brn × CAR free,brn
− Kd TAR,brn × k1 TAR,brn × CTAR,brn) − (k1 TBAR,brn × CTB,brn × CAR free,brn
− Kd TBAR,brn × k1 TBAR,brn × CTBAR,brn) − ke AR,brn × CAR free,brn
(4)
where, CAR_free, brn (nmol/L) is the free AR concentra-
tion in brain; PbgAR, brn (nmol/L/hr) is the background
production rate of AR in brain; CT,b r n(nmol/L) is the
free T concentration in brain; CTB, brn (nmol/L) is the
free TB concentration in brain; KAR, brn (nmol/L) is an
inhibition rate constant for AR production by free
T and TB; k1_TAR, brn (L/nmol/hr) is the association rate
Li et al. BMC Systems Biology 2011, 5:63
http://www.biomedcentral.com/1752-0509/5/63
Page 4 of 22constant for T and AR; Kd_TAR, brn (nmol/L) is the
dissociation rate constant for T bound to AR; CTAR, brn
(nmol/L) is the concentration of the T-AR complex in
brain; k1_TBAR, brn (L/nmol/hr) is the association rate of
TB to AR; Kd_TBAR, brn (nmol/L) is the dissociation rate
constant for TB bound to AR; CTBAR, brn (nmol/L) is the
concentration of the TB-AR complex in brain; and
ke_AR, brn (1/hr) is the elimination rate for free AR. We
included the inhibition of LH by bound AR and the
inhibition of AR by free androgens to account for the
U-shaped dose-response curves for plasma E2,Ta n d
VTG concentrations observed in female FHMs exposed
to TB [7]. These assumptions and mathematical formu-
lations provided a robust fit to the available data [7]. An
alternate formulation based upon brain AR and gonad
AR with different binding affinities was tried first. How-
ever, because of a lack of parameter information and
evidence for the biological mechanism, we abandoned
this approach for the present version. The present
model formulation makes more sense biologically, and is
simpler.
Gonad
In the gonad compartment, modifications to the model
formulations for male FHMs include (i) absorption of
VTG into oocytes; and (ii) up-regulation of E2 produc-
tion by bound LH. The absorption of VTG into oocytes
was formulated as a first order kinetic process. VTG is
synthesized in the liver [30], and circulates to the
gonads where it is taken up via receptor-mediated endo-
cytosis into oocytes, and then processed into yolk pro-
teins [31]. Although the molecular mechanism of VTG
uptake is known, we did not have data to describe this
process quantitatively. As a result, a first order kinetic
equation with an assumed first order rate constant was
formulated to represent the process (Equation 5).
RVTG,gon = kVTG,gon × CVTG,gon × Vgon (5)
where, RVTG, gon (nmol/hr) is the absorption rate of
VTG into oocytes in the gonad compartment; kVTG, gon
(1/hr) is the absorption rate constant for VTG into
oocytes in the gonad compartment; CVTG, gon (nmol/L)
is the concentration of VTG in the gonad compartment;
and Vgon (1/L) is the volume of the gonad compartment.
Secondly, we simulated an up-regulation of E2 produc-
tion by bound LH in the gonad compartment. It was
observed that LH stimulates the activity and gene
expression of aromatase in the gonads of teleosts [32].
In our model, we formulated the regulation of E2 pro-
duction as being proportional to the concentration of
bound LH in the gonad compartment (Equation 6).
PE2,gon =
ρE2 LHLR,gon × CLHLR,gon × Vmaxaro,gon × CT,gon
Kmaro,gon + CT,gon
(6)
where, PE2, gon (nmol/hr) is the rate of E2 production;
rE2_LHLR, gon (L/nmol) is an induction factor of E2
production by bound LH; CLHLR, gon (nmol/L) is the
concentration of bound LH; Vmaxaro, gon (nmol/hr) is
the maximum rate of E2 production by gonad aroma-
tase; Kmaro, gon (nmol/L) is the Michaelis-Menten con-
stant for gonad aromatase; CT,g o n(nmol/L) is the
concentration of T.
Liver
In the liver compartment, formulations including ER
auto-regulation and bound-ER-stimulated VTG produc-
tion are the same as those described by Watanabe et al.
[20], except that we added ligand-receptor binding of T
and TB to the AR.
Venous blood
Besides E2 and T, we simulated the association and dis-
sociation processes of EE2 to steroid-binding proteins
(SBPs) in the venous blood compartment. There is con-
tradictory information about the binding affinities of
EE2 to SBPs in fish. Compared to E2,s o m ef i s hs p e c i e s
such as channel catfish (Ictalurus punctatus) and zebra-
fish (Danio rerio) have high binding affinity of EE2 to
SBPs [33,34], while other fish species such as Arctic
charr (Salvelinus alpinus) have a low binding affinity
[35]. To date, binding affinity measurements of EE2 to
SBPs in FHM have not been made. Watanabe et al. [20]
did not include the binding process of EE2 to SBPs in
blood. In their modelling work for male FHMs, the total
concentration of SBPs was assumed to be 20 nmol/L
based upon a measurement in human males [36]. Such
al o wv a l u eh a sl i t t l ee f f e c to nf r e ep l a s m aE E 2 concen-
tration or model performance. However, in our model
for female FHMs, we assumed the total concentration of
SBPs to be 400 nmol/L [36,37] based upon SBP mea-
surements in female spotted seatrout (Cynoscion nebulo-
sus) [37] and in human females [36]. Consequently, a
large amount of EE2 could be bound by SBPs in blood,
which would affect the total concentration of EE2 in the
plasma. Therefore, we included the binding process of
EE2 to SBPs in this model, and formulated it using
Equation 1.
Other
In our model, the ‘Other’ compartment is where elimi-
nation of exogenous and endogenous chemicals and
proteins occur. Besides E2,E E 2,T ,V T G ,a n dL H
(included in Watanabe et al. [20]), we added a first
order kinetic equation to describe the elimination of TB,
and the first order elimination rate constant was
assumed to be the same as that of EE2 (Equation 7).
RTB,oth = ke TB,oth × CTB,oth × Voth (7)
where RTB, oth (nmol/hr) is the elimination rate of TB
in the Other compartment; ke_TB, oth (1/hr) is the
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http://www.biomedcentral.com/1752-0509/5/63
Page 5 of 22elimination rate constant for TB in the Other compart-
ment; CTB, oth (nmol/L) is the concentration of TB in
the Other compartment; and Voth (1/L) is the volume of
the Other compartment.
Experimental Data
To calibrate model parameters and to evaluate model
predictions, we used data from unexposed, TB-exposed,
and EE2-exposed adult female FHMs from 18 different
studies. All studies were conducted with sexually mature
(five to seven month old) female FHMs. Chemical expo-
sures were conducted in the laboratory under optimal
conditions for FHM reproduction. For example, the
temperature was 25°C, photoperiod was 16/8 hr (light to
dark), and food was not limited. Under such conditions,
FHMs can remain in reproductive condition and spawn
year around. For each fish, physiological parameters,
including body weight (BW), gonadosomatic index
(GSI), and hepatosomatic index (HSI), were input into
the model. For all experimental data used in model cali-
bration or validation, when any measurements of BW,
GSI, or HSI were missing, we used the medians of mea-
sured BW, GSI, or HSI, respectively [38]. Ideally, if all
experimental data had been available when we started to
develop the model in 2006, we would have randomly
selected a subset of data from each experiment for
model calibration and used the remainder for model
evaluation. However, several of the experimental studies
were conducted while the model was being developed.
Thus, we used data as they became available. The fol-
lowing summarizes the experimental data and how the
data were used.
T h er e p r o d u c t i v ee n d p o i n td a t ai nu n e x p o s e d( c o n -
trol) adult female FHMs were obtained from an earlier
paper by Watanabe et al. [38]. In a total of 170 female
FHMs, the data include measurements of plasma E2,T ,
and VTG concentrations; all measurements were made
in some fish, and in others only a subset of endpoints
(e.g., plasma E2 and VTG concentrations) were mea-
sured. We randomly split the data; the first 75 records
were used to calibrate our model; the remaining 95
records were used in model validation.
Experimental data from TB-exposed adult female
FHMs were obtained from three studies: (i) a flow-
through water exposure to nominal concentrations of
0.005, 0.05, 0.5, 5.0, and 50 μg TB/L for 21 days by
Ankley et al. [7]; (ii) a static exposure to nominal con-
centrations of 0.05, 0.5, 5 μg TB/L for 48 hours by Gar-
cia-Reyero et al. [39]; and (iii) a flow-through water
exposure to nominal concentrations of 0.05 and 0.5 μg
TB/L in adult female FHMs for eight days, followed by
an eight-day depuration described by Ekman et al. [40].
In Ankley et al. [7], 12 female FHMs were exposed in
each treatment group. On the 21
st day of exposure, all
FHMs were sacrificed; plasma concentrations of E2,T ,
and VTG were measured in each fish. In Garcia-Reyero
et al. [39] eight FHMs were exposed in each treatment
group. After a 48-hour exposure, the fish were sacri-
ficed. For each treatment group, plasma E2 concentra-
tions were measured in each of four fish, and plasma
VTG concentrations were measured in each of the four
remaining fish. The concentrations of VTG and E2 were
not measured in the same fish because Dr. Orlando’s
laboratory measured E2 and Dr. Denslow’s laboratory
measured VTG. In Ekman et al. [40], 64 FHMs were
exposed to TB in each treatment group. On the 1
st,2
nd,
4
th, and 8
th day of exposure and the 1
st,2
nd,4
th,a n d8
th
day of depuration (test days 9, 10, 12, and 16), for each
treatment group, eight FHMs were sacrificed to measure
plasma E2 and VTG concentrations in each fish. Data
from Ankley et al. [7] were used to calibrate our model,
and data from Garcia-Reyero et al. [39] and Ekman et
al. [40] were used to evaluate our model predictions.
VTG plasma concentrations in adult female FHMs
exposed to EE2 were obtained from three studies: (i) a
flow-through water exposure to nominal concentrations
of 10 or 100 ng EE2/L in adult female FHMs for eight
days, followed by an eight-day depuration [41]; (ii) a
flow-through water exposure to a nominal concentration
of 0.5, 1.5, and 4.5 ng EE2/L in adult female FHMs for
21 days by Lazorchak et al. [42]; and (iii) a flow-through
water exposure to a nominal concentration of 1.5 ng
EE2/L in adult female FHMs for 21 days by Brian et al.
[43]. In Ekman et al. [41], for each treatment group and
each sampling time, eight FHMs were sacrificed to mea-
sure plasma VTG concentration in each fish. Sampling
occurred on the 1
st,4
th,a n d8
th d a yo fe x p o s u r et oE E 2,
and the 8
th day of EE2 depuration (test day 16). In
Lazorchak et al. [42], 28 FHMs in each of the treatment
groups (0.5, 1.5, and 4.5 ng EE2/L) were sacrificed to
measure plasma VTG concentration in each fish on the
21
st day. In Brian et al. [43], four FHMs were sacrificed
to measure plasma VTG concentration in each fish on
the 21
st day after exposure to 1.5 ng EE2/L. As opposed
to the three TB and two EE2 studies which did not use
carrier solvents, Brian et al. [39] used N, N-dimethylfor-
mamide, DMF, as a chemical carrier for EE2. Data from
Ekman et al. [41] were used to calibrate our model, and
data from Lazorchak et al. [42], and Brian et al. [43]
were used to evaluate our model predictions.
Model Calibration
In total, our model contains 123 input parameters, such
as volume and blood flow rates of each compartment,
chemical equilibrium partition coefficients, ligand-recep-
tor association and dissociation rate constants, and
kinetic rate constants for each biochemical reaction.
The parameters were fixed with known values, or
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female FHMs. In total, 97 model parameters were fixed
with values obtained from published literature or mea-
sured for this study (Table 1). The remaining 26 model
parameters were calibrated using Markov Chain Monte
Carlo simulation [44-47], which requires the definition
of prior distributions for each parameter being
calibrated.
Of the 26 calibrated model parameters, 17 were sensi-
tive model parameters with little or no information
available in the open literature (Table 2). Vague prior
distributions were used for these 17 model parameters.
For example, we could not find a published value for
the dissociationc o n s t a n to fE 2 binding to ER in FHM
brain specifically (Kd_E2ER, brn). Denny et al. [15]
reported that the dissociation constant of E2 binding in
female FHM liver cytosol is 8.6 nmol/L. As a result, we
assigned a lognormal distribution with a geometric
mean of 8.6 and a geometric standard deviation of
three, which corresponds to a coefficient of variation
e q u a lt o1 . 5 .W h e nn od a t aw e r ea v a i l a b l ei nt h eo p e n
literature, we assigned a uniform or log-uniform prior
distribution with a large range bounded by biological
plausibility. For example, we know that the EE2 partition
coefficient for blood to water is around 300 [20], and
thus fixed the parameter value at 300. However, there
were no published data for the blood to water TB parti-
tion coefficient (lTB, bld). Therefore, we assigned a vague
prior distribution for lTB, bld,w h i c hi sal o g - u n i f o r m
distribution with a lower bound of one and an upper
bound of 1000.
The remaining nine parameters were error variances
for plasma E2,T ,a n dV T Gc o n c e n t r a t i o n si nu n e x -
posed, TB-exposed, and EE2-exposed FHMs. We
assumed that the errors followed a lognormal distribu-
tion with geometric means equal to the model-predicted
concentrations of plasma E2,T ,a n dV T G ,r e s p e c t i v e l y .
The variance was estimated by dividing the experimental
data into three different groups: unexposed, TB-exposed,
and EE2-exposed FHM, respectively; and the error var-
iances of the three reproductive endpoints for each
group were estimated [45,47]. For each of the nine error
variances, we assigned an Inverse Gamma prior distribu-
tion based upon a natural logarithm transformation of
the measured plasma E2, T and VTG concentrations
[20]. An Inverse Gamma prior distribution is the conju-
gate of a normal distribution [46], which simplifies the
model computations.
To perform the Markov Chain Monte Carlo simula-
tions, we used MCSim [48], a software package freely
available online http://directory.fsf.org/math/mcsim.
html. Four independent Markov chains with random
seeds were run for 20,000 iterations. For each of the
four chains, we saved the last 10,000 iterations, and
extracted one set of model parameters out of every 10.
For each calibrated model parameter, convergence was
evaluated using the 1,000 iterations from each chain and
a potential scale reduction criterion (Rhat) [46]. Accep-
table values of Rhat ranged from 1.0 to 1.2; this is essen-
tially a ratio of the calibrated model parameter variance
between the four Markov chains to the variance within
a chain.
Model Evaluation
We evaluated the predictive ability of our model by
simulating reproductive endpoints (i.e., plasma concen-
trations of E2, T, or VTG) from independent studies.
The 1,000 iterations obtained from each Markov chain
were pooled, and the 4,000 sets of parameter values
were treated as a pool of adult female FHMs. We ran-
domly sampled n (number of fish in a study) parameter
sets to represent the n fish used in the study, and simu-
lated the reproductive endpoints measured for each fish.
The detailed simulation procedures followed the meth-
ods described by Watanabe et al. [20].
After completing n simulations for a study, we predicted
each reproductive endpoint based upon our lognormal
error model. As described in the Model Calibration sec-
tion, error variances were estimated during model calibra-
tion. Using the model prediction and the estimated
variance as two parameters, we randomly sampled from
the lognormal distribution for each endpoint in each fish.
The sampled values were compared with experimental
measurements.
Prediction of Unmeasured Reproductive Endpoints
To observe EDC effects on unmeasured components of
the HPG axis (e.g., ER, AR, and LH), and to observe the
effects on reproductive endpoints by a mixture of TB
and EE2, we did three extra simulations. We simulated
liver ER concentration, brain AR concentration, and
plasma E2, T, VTG, and LH concentrations as a func-
tion of time in adult female FHMs exposed to 15 ng
TB/L, 10 ng EE2/L, or a mixture of 15 ng TB/L and
10 ng EE2/L for 48 hours, respectively. The concentra-
tions of TB and EE2 were chosen because they are
environmentally relevant [12,18,19]. In all three simula-
tions, we used the reported [38] median body weight,
GSI, and HSI values in adult female FHMs as input
parameters.
Results and Discussion
Model Calibration
A good fit of the experimental data was obtained by
running four Markov chains using the Markov Chain
Monte Carlo simulations. For the 26 calibrated model
parameters, the four Markov chains converged within
20,000 iterations. The model calibration speed is around
Li et al. BMC Systems Biology 2011, 5:63
http://www.biomedcentral.com/1752-0509/5/63
Page 7 of 22Table 1 Model parameters treated as constants (n = 97)
Parameter description Symbols Value Reference
Body weight
a BodyWt 0.0016 (kg) Watanabe et al. [38]
Volumetric water flowing through gills FWgil 10.6× BodyWt
0.75 (L/hr) Nichols et al. [57]
Cardiac output Fcar 2.06× BodyWt
0.75 (L/hr) Nichols et al. [57]
Percentage of brain to body weight (BSI) Pbrn 1.18 Measured by D. Villeneuve
Percentage of gonads to body weight (GSI)
b Pgon 11 Watanabe et al. [38]
Percentage of liver to body weight (HSI)
c Pliv 3.0 Watanabe et al. [38]
Percentage of gills to body weight Pgil 1.67 Nichols et al. [58]
Percentage of venous blood to body weight Pven 2.59 Robinson et al. [59]
Nichols et al. [58]
Percentage of “other” to body weight Poth = 100- Pbrn-P gon-P liv-P gil-P ven Watanabe et al. [20]
Fraction of blood flow in brain to cardiac output
Fbrn
Fcar
0.036 × Pbrn
0.036 × Pbrn +0 . 0 3 6× Pgon +0 . 0 2 4× Pliv +0 . 0 0 7× Poth
Nichols et al. [58]
Fraction of blood flow in gonad to cardiac output
Fgon
Fcar
0.036 × Pgon
0.036 × Pbrn +0 . 0 3 6× Pgon +0 . 0 2 4× Pliv +0 . 0 0 7× Poth
Nichols et al. [58]
Fraction of blood flow in liver to cardiac output
Fliv
Fcar
0.024 × Pliv
0.036 × Pbrn +0 . 0 3 6× Pgon +0 . 0 2 4× Pliv +0 . 0 0 7× Poth
Nichols et al. [58]
Fraction of blood flow in “other” to cardiac output
Foth
Fcar
0.007 × Poth
0.036 × Pbrn +0 . 0 3 6× Pgon +0 . 0 2 4× Pliv +0 . 0 0 7× Poth
Nichols et al. [58]
Fraction of plasma in venous blood Fplasma, ven 0.45 Measured by K. Kroll
Total concentration of estrogen receptors in brain CER, brn 14.3 (nmol/L tissue) Plowchalk and Teaguarden
[60]
Total concentration of estrogen receptors in gonad CER, gon 29 (nmol/L tissue) Plowchalk and Teaguarden
[60]
Total concentration of LH receptors in gonad CLR, gon 2.0 (nmol/L tissue) Miwa et al. [61]
Total concentration of SBP in blood CSBP, ven 400 (nmol/L blood) Laidley and Thomas[37]
Teeguarden and Barton [36]
Total concentration of AR in gonad CAR, gon 1.05 (nmol/L tissue) Sperry and Thomas [62]
Total concentration of AR in liver CAR, liv =C AR, gon assumed
Association rate of E2 to estrogen receptor in brain k1_E2ER, brn 0.743 Murphy et al. [63]
Dissociation constant of E2 to estrogen receptor in gonad Kd_E2ER, gon = Kd_E2ER, brn assumed
Association rate of E2 to estrogen receptor in gonad k1_E2ER, gon = k1_E2ER, brn assumed
Dissociation constant of E2 to estrogen receptor in liver Kd_E2ER, liv = Kd_E2ER, brn assumed
Association rate of E2 to estrogen receptor in liver K1_E2ER, liv = k1_E2ER, brn assumed
Dissociation constant of EE2 to estrogen receptor in brain Kd_EE2ER, brn = Kd_E2ER, brn/RBAEE2_E2 Denny et al. [15]
Association rate of EE2 to estrogen receptor in brain k1_EE2ER, brn = k1_E2ER, brn assumed
Dissociation constant of EE2 to estrogen receptor in gonad Kd_EE2ER, gon = Kd_EE2ER, brn assumed
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2Table 1 Model parameters treated as constants (n = 97) (Continued)
Association rate of EE2 to estrogen receptor in gonad k1_EE2ER, gon = k1_EE2ER, brn assumed
Dissociation constant of EE2 to estrogen receptor in liver Kd_EE2ER, liv = Kd_EE2ER, brn assumed
Association rate of EE2 to estrogen receptor in liver k1_EE2ER, liv = k1_EE2ER, brn assumed
Dissociation constant of T to androgen receptor in brain Kd_TAR, brn 3 (nmol/L) Sperry and Thomas [62]
Association rate of T to androgen receptor in brain k1_TAR, brn 0.08 (L/nmol/hr) Sperry and Thomas [62]
Dissociation constant of T to androgen receptor in gonad Kd_TAR, gon = Kd_TAR, brn assumed
Association rate of T to androgen receptor in gonad k1_TAR, gon = k1_TAR, brn assumed
Dissociation constant of T to androgen receptor in liver Kd_TAR, liv = Kd_TAR, brn assumed
Association rate of T to androgen receptor in liver k1_TAR, liv = k1_TAR, brn assumed
Dissociation constant of TB to androgen receptor in brain Kd_TBAR, brn = Kd_TAR, brn/RBATB_T Wilson et al. [64]
Association rate of TB to androgen receptor in brain k1_TBAR, brn = k1_TAR, brn assumed
Dissociation constant of TB to androgen receptor in gonad Kd_TBAR, gon = Kd_TBAR, brn assumed
Association rate of TB to androgen receptor in gonad k1_TBAR, gon = k1_TBAR, brn assumed
Dissociation constant of TB to androgen receptor in liver Kd_TBAR, liv = Kd_TBAR, brn assumed
Association rate of TB to androgen receptor in liver k1_TBAR, liv = k1_TBAR, brn assumed
Dissociation constant of E2 to SBP in blood Kd_E2SBP, ven 3.13 (nmol/L) Murphy et al. [63]
Association rate of E2 to SBP in blood k1_E2SBP, ven 5.6687 (L/nmol/hr) Murphy et al. [63]
Dissociation constant of T to SBP in blood Kd_TSBP, ven 4.89 (nmol/L) Murphy et al. [63]
Association rate of T to SBP in blood K1_TSBP, ven 5.6687 (L/nmol/hr) Murphy et al. [63]
Dissociation constant of EE2 to SBP in blood Kd_EE2SBP, ven 0.58 (nmol/L) Miguel-Queralt and
Hammond [34]
Association rate of EE2 to SBP in blood k1_EE2SBP, ven 5.6687 (L/nmol/hr) Murphy et al. [63]
Dissociation constant of LH to LH receptor in gonad Kd_LHLR, gon 2.9 (nmol/L) Crim et al. [65]
Association rate of LH to LH receptor in gonad k1_LHLR, gon 0.2 (L/nmol/hr) Watanabe et al. [20]
Scaling coefficient of Vmax of T production in gonad (= Vmax/bodyweight
0.75) sc_VmaxScc,
gon
1.1e+05 (nmol/hr/kg body weight) Kashiwagi et al. [66];
Shikita and Hall [67]
K0.5 of T production in gonad K0.5Scc, gon 190 (nmol/L) Shikita and Hall [67]
Inhibition constant of T production by bound ER KT 0.016 Watanabe et al. [20]
Km of E2 production in gonad Kmaro, gon 9.6 (nmol/L) Zhao et al. [68]
Concentration of microsomal protein in gonads Dmp, gon 3100 (mg/L) Measured by D. Villeneuve
Ratio between the concentrations of microsoaml protein in gonads and brain Rhomp 0.174 Measured by D. Villeneuve
Scaling coefficient of Vmax of E2 production in brain (= Vmax/mass of microsomal protein
in brain)
sc_Vmaxaro,
brn
= 4.6× sc_Vmaxaro, gon Zhao et al. [68]
Km of E2 production in brain Kmaro, brn 9.6 (nmol/L) Zhao et al. [68]
Concentration of microsomal protein in brain Dmp, brn =D mp, gon/Rhomp Measured by D. Villeneuve
Ratio between concentrations of STAR and bound LR in gonads RhoSTAR, gon 1 assumed
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2Table 1 Model parameters treated as constants (n = 97) (Continued)
Rate constant for Vtg uptake into oocytes kvtg, gon 0.05 assumed
K0.5 of Vtg production in liver production K0.5Vtg, liv 1.0 (nmol/L) Watanabe et al. [20]
Elimination rate constant for ER
in the liver compartment
ke_ER, liv 0.01 (1/hr) Murphy et al. [63]
Elimination rate constant for AR
in the brain compartment
ke_AR, brn 0.01 (1/hr) Assumed
Elimination rate constant for LH
in the “other” compartment
ke_LH, oth 0.1 (1/hr) Teeguarden and Barton [36]
Elimination rate constant for E2
in the “other” compartment
ke_E2, oth 0.1 (1/hr) Teeguarden and Barton [36]
Elimination rate constant for T
in the “other” compartment
ke_T, oth 0.1 (1/hr) Teeguarden and Barton [36]
Elimination rate constant for EE2
in the “other” compartment
ke_EE2, oth 0.1 (1/hr) Teeguarden and Barton [36]
Elimination rate constant for TB
in the “other” compartment
ke_TB, oth 0.1 (1/hr) Teeguarden and Barton [36]
Elimination rate constant for Vtg
in the “other” compartment
ke_Vtg, oth 0.001 (1/hr) Teeguarden and Barton [36]
Partition coefficient of LH
(brain to blood)
lLH, brn 1 Teeguarden and Barton [36]
Partition coefficient of LH
(gonad to blood)
lLH, gon 1 Teeguarden and Barton [36]
Partition coefficient of LH
(liver to blood)
lLH, liv 1 Teeguarden and Barton [36]
Partition coefficient of LH
("other” to blood)
lLH, oth 1 Teeguarden and Barton [36]
Partition coefficient of VTG
(brain to blood)
lVTG, brn 1 Teeguarden and Barton [36]
Partition coefficient of VTG
(gonad to blood)
lVTG, gon 1 Teeguarden and Barton [36]
Partition coefficient of VTG
(liver to blood)
lVTG, liv 1 Teeguarden and Barton [36]
Partition coefficient of VTG
("other” to blood)
lVTG, oth 1 Teeguarden and Barton [36]
Partition coefficient of EE2
(blood to water)
lEE2, bld 300 Watanabe et al. [20]
Partition coefficient of EE2
(brain to blood)
lEE2, brn 1 Teeguarden and Barton [36]
Partition coefficient of EE2
(gonad to blood)
lEE2, gon 1 Teeguarden and Barton [36]
Partition coefficient of EE2
(liver to blood)
lEE2, liv 3 Watanabe et al. [20]
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2Table 1 Model parameters treated as constants (n = 97) (Continued)
Partition coefficient of EE2
("other” to blood)
lEE2, oth 1 Teeguarden and Barton [36]
Partition coefficient of E2
(blood to water)
lE2, bld 300 Watanabe et al. [20]
Partition coefficient of E2
(brain to blood)
lE2, brn 1 Teeguarden and Barton [36]
Partition coefficient of E2
(gonad to blood)
lE2, gon 1 Plowchalk and Teeguarden
[60]
Partition coefficient of E2
(liver to blood)
lE2, liv 3 Watanabe et al. [20]
Partition coefficient of E2
("other” to blood)
lE2, oth 1 Plowchalk and Teeguarden
[60]
Partition coefficient of T
(brain to blood)
lT, brn 1 Barton and Andersen [69]
Partition coefficient of T
(gonad to blood)
lT, gon 1 Barton and Andersen [69]
Partition coefficient of T
(liver to blood)
lT, liv 1 Barton and Andersen [69]
Partition coefficient of T
("other” to blood)
lT, oth 1 Barton and Andersen [69]
Partition coefficient of TB
(brain to blood)
lTB, brn 1 Barton and Andersen [69]
Partition coefficient of TB
(gonad to blood)
lTB, gon 1 Barton and Andersen [69]
Partition coefficient of TB
(liver to blood)
lTB, liv 1 Barton and Andersen [69]
Partition coefficient of TB
("other” to blood)
lTB, oth 1 Barton and Andersen [69]
a,
b, and
c were assigned with measured values in each fish; the default values were used only when measured data were missing.
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2Table 2 Summary statistics for prior and posterior distributions of calibrated model parameters (n = 26)
Parameter description Symbols Prior
Distribution
(P1, P2)
a
Reference Mean (Posterior
Distribution)
Median (Posterior
Distribution)
95% Confidence Interval
(Posterior Distribution)
Partition coefficient of TB (blood to water) lTB, bld Loguniform
(1, 1.0E+3)
Assumed 7.47 7.47 (5.96, 8.93)
Dissociation constant of E2 binding to ER in
brain (nmol/L)
Kd_E2ER, brn Lognormal
(8.6, 3)
Denny et al. [15] 1.12 1.08 (0.71, 1.87)
Relative binding affinity of EE2 to E2 for ER binding RBAEE2_E2 Lognormal
(1.66, 3)
Denny et al. [15]
Gale et al. [14]
3.24 1.64 (0.030, 16.79)
Relative binding affinity of TB to T for AR binding RBATB_T Lognormal
(6.03, 3)
Wilson et al. [64] 5.25 4.84 (2.29, 10.76)
Inhibition factor for LH production by bound
AR (nmol/L)
rd_LH, brn LogUniform
(0.01, 1.0E+3)
Assumed 0.11 0.10 (0.042, 0.21)
Induction factor for LH production by bound
ER (nmol/L)
ru_LH, brn LogUniform
(0.01, 1.0E+3)
Assumed 238 138 (4.23, 864)
Hill coefficient for T production nT Lognormal
(1.8, 3)
Murphy et al. [63] 1.03 1.01 (0.93, 1.19)
Proportionality constant relating cholesterol to StAR rChol, gon Loguniform
(1, 5.0E+3)
Artemenk et al. [70] 2.37 1.83 (1.04, 6.69)
Scaling coefficient of Vmax for E2 production in
gonad (nmol/hr/mg micro-protein)
sc_Vmaxaro, gon Loguniform
(2.3E-5, 0.23)
Zhao et al. [71] 1.56E-3 1.53E-3 (1.15E-3, 2.12E-3)
Induction factor of E2 production by bound
LH (L/nmol)
rE2_LHLR, gon Loguniform
(0.1, 100)
assumed 79.84 82.79 (42.61, 99.15)
Scaling coefficient of Vmax for Vtg production in
liver (= Vmax/BodyWeight
0.75) (nmol/hr/kg
0.75)
sc_VmaxVtg, liv Loguniform
(1, 1.0E+4)
Watanabe et al. [20] 175 169 (121, 271)
Hill coefficient of Vtg production in liver nVTG Uniform
(1, 10)
Assumed 2.88 2.87 (1.97, 3.87)
ER background production rate in liver (nmol/L/hr) PbgER, liv Loguniform
(5.0E-5, 0.5)
assumed 0.12 0.12 (0.084, 0.17)
Induction rate constant for ER production in
liver (1/hr)
kER, liv Lognormal
(0.08, 3)
Watanabe et al. [20] 0.027 0.025 (5.73E-3, 0.065)
AR background production rate in brain
(nmol/L/hr)
PbgAR, brn Loguniform
(5.0E-5, 0.5)
assumed 0.012 0.012 (9.1E-3, 0.015)
Inhibition factor of AR production by free
androgens (nmol/L)
KAR, brn Loguniform
(5E-4, 5)
assumed 3.95 4.08 (2.15, 4.95)
Magnitude of LH production (nmol/hr) MagLH Loguniform
(2.7E-7, 2.7E-3)
Schulz et al. [72] 8.86E-6 8.75E-6 (6.29E-6, 1.20E-5)
Error variance of plasma E2 concentration in natural
log space for unexposed female FHMs
Var_Ln_CE2tot_pla_ngml Inverse Gamma
(2, 1.19)
Bois et al. [73] 0.52 0.51 (0.38, 0.73)
Error variance of plasma T concentration in natural
log space for unexposed female FHMs
Var_Ln_CTtot_pla_ngml Inverse Gamma
(2, 0.53)
Bois et al. [73] 0.48 0.47 (0.34, 0.69)
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2Table 2 Summary statistics for prior and posterior distributions of calibrated model parameters (n = 26) (Continued)
Error variance of plasma VTG concentration in
natural log space for unexposed female FHMs
Var_Ln_CVTG_pla_mgml Inverse Gamma
(2, 5.31)
Bois et al. [73] 0.49 0.48 (0.35, 0.68)
Error variance of plasma E2 concentration in natural
log space for TB-exposed female FHMs
Var_Ln_CE2tot_pla_ngml Inverse Gamma
(2, 1.19)
Bois et al. [73] 0.70 0.69 (0.48, 1.03)
Error variance of plasma T concentration in natural
log space for TB-exposed female FHMs
Var_Ln_CTtot_pla_ngml Inverse Gamma
(2, 0.53)
Bois et al. [73] 0.40 0.39 (0.27, 0.60)
Error variance of plasma VTG concentration in
natural log space for TB-exposed female FHMs
Var_Ln_CVTG_pla_mgml Inverse Gamma
(2, 5.31)
Bois et al. [73] 5.86 5.72 (3.98, 8.60)
Error variance of plasma E2 concentration in natural
log space for EE2-exposed female FHMs
Var_Ln_CE2tot_pla_ngml Inverse Gamma
(2, 1.19)
Bois et al. [73] 1.43 0.81 (0.22, 6.31)
Error variance of plasma T concentration in natural
log space for EE2-exposed female FHMs
Var_Ln_CTtot_pla_ngml Inverse Gamma
(2, 0.53)
Bois et al. [73] 0.59 0.34 (0.10, 2.76)
Error variance of plasma VTG concentration in
natural log space for EE2-exposed female FHMs
Var_Ln_CVTG_pla_mgml Inverse Gamma
(2, 5.31)
Bois et al. [73] 0.73 0.71 (0.51, 1.03)
a Definition of P1 and P2 of prior distributions. Loguniform: P1 = minimum of the sampling range in natural space; P2 = maximum of the sampling range in natural space. Lognormal: P1 = geometric mean
(exponential of the mean in log-space); P2 = geometric standard deviation (exponential of the standard deviation in log-space, strictly superior to 1). Uniform: P1 = minimum of the sampling range in natural space;
P2 = maximum of the sampling range in natural space. Inverse gamma: P1 = shape; P2 = scale (both of the parameters are strictly positive).
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212 hours per 100 iterations. The Rhat values of the 26
parameters were all less than 1.2, indicating acceptable
convergence. Figure 2 plots the trajectories of the four
Markov chains for the relative binding affinity of TB to
T( R B A TB_T), which is one of the 26 calibrated model
parameters. The four chains for this parameter mixed
well and converged within 20,000 iterations.
Table 2 includes the summary statistics of posterior
distributions for the 26 calibrated parameters. The pos-
terior distribution summary statistics are based on the
4,000 iterations, 1,000 iterations from each of the four
chains. In brief, our model improved estimates of 23
model parameters. Of the 26 parameters, 21 had 95%
confidence intervals (CIs) narrower than those of their
prior distributions; three parameters (i.e., RBAEE2_E2,
error variances of E2 and T for EE2-exposed FHMs) had
95% CIs similar to their prior distribution CIs; and two
parameters (i.e., error variances of VTG in unexposed
and EE2-exposed FHMs) had 95% CIs slightly different
from their prior distribution CIs. For the error variance
of VTG in unexposed FHMs, the upper 95% confidence
limit of the posterior distribution was 72% of the 2.5
th
percentile of its prior distribution. For the error var-
iances of VTG in EE2-exposed FHMs, the 95% CIs of
the prior and posterior distributions overlapped with
each other. But the upper 95% confidence limit of the
posterior distribution was only 5% of the 97.5
th percen-
tile of its prior distribution. These large differences
occurred mainly because the assigned prior distributions
for the error variances were based upon experimental
data variances, which do not represent the errors
exactly, but were good starting points for the model
calibration.
It is important to note that the posterior distributions
listed in Table 2 are conditional upon fixed model para-
meters (Table 1), prior distributions of calibrated para-
meters (Table 2), and the data sets used in calibration.
Any change in these components may lead to different
posterior distributions of the calibrated parameters. In
this study, we carefully searched the literature to assign
our model parameters with meaningful and physiologi-
cally based values or prior distributions. As additional
data become available, our model could be re-calibrated
to better define parameter posterior distributions.
Model Evaluation
In this study, our model was used to simulate experi-
ments ranging in length from 48 hrs to 21 days. The
model is capable of simulating longer periods of time,
but it does not include a seasonal component. That is,
the FHMs simulated in our study were held under
laboratory conditions optimal for reproduction and
spawn year round. The model could be modified to
account for the effect of seasons upon reproduction in
order to simulate conditions experienced by wild fish.
Predictions for Plasma E2, T, and VTG Concentrations in
Unexposed FHMs
With the calibrated model parameters, we simulated
plasma concentrations of E2, T, and VTG in 95 unexposed
adult female FHMs [38]. Figure 3 shows a comparison of
model predictions and experimental data. For all three
endpoints, the mean and median model predictions were
within 80 to 150% of the measured means and medians,
respectively. Model-predicted 95% CIs encompassed the
mean and median measurements, and model-predicted
means and medians were within the 95% CIs of the mea-
sured data. Thus, in unexposed adult female FHMs, our
model successfully predicted all three endpoints (Figure
3 ) .T h i si sa ni m p r o v e m e n tcompared to the model for
male FHMs [20], which predicted the medians of the mea-
sured data, but under-predicted the variances for all three
endpoints. Including information from the lognormal
error model enabled better predictions of both medians
and variances of the measured data.
Predictions for plasma E2 and VTG concentrations in TB-
exposed FHMs
Figure 4 compares the measured and model-predicted
plasma VTG (Figure 4A) and E2 (Figure 4B) concentra-
tions in female FHMs exposed to 0, 0.05, 0.5, and 5 μg
TB/L for 48 hours [39]. Our model predictions fol-
lowed the general trend of the measured data, and the
model prediction range overlapped with the measured
data range for both endpoints at each TB concentra-
tion. For plasma VTG concentrations, the median
model predictions were within 96% to 579% of the
Figure 2 Four Markov chains. Androgen receptor relative binding
affinity (RBA) for TB relative to T (RBATB_T). This is one of the 26
calibrated model parameters illustrating well-mixed Markov chain
trajectories.
Li et al. BMC Systems Biology 2011, 5:63
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high, and as a result, we looked into details particularly
for this model prediction. We found that this predic-
tion happened when TB concentration equal to 0.5 μg/
L. At this TB concentration, we collected plasma VTG
concentrations in each of 4 adult female FHMs, which
were 4.61, 26.21, 1.99, and 0.06 mg/ml. The last mea-
surement (0.06 mg VTG/ml) is more than 30-fold
lower than the second lowest measurement (1.99 mg
VTG/ml). As a result, this data point is an outlier, and
our model did not capture it. If we exclude this data
point, our model predictions (17.63, 20.54, and 5.07
mg/ml) would match the experimental data well. For
plasma E2 concentrations, the median model predic-
tions were within 44 to 113% of the median measure-
ments. Kolmogorov-Smirnov tests (a =0 . 0 5 )s h o w e d
that the model predictions were not significantly differ-
ent from the measured data for both plasma VTG and
E2 concentrations.
To further evaluate the model’s predictive ability for
TB-exposed FHMs, we simulated plasma E2 and VTG
concentrations in FHMs exposed to 0, 0.05, and 0.5 μg
TB/L for 8 days followed by an 8-day depuration [40].
For plasma E2 concentrations (Figure 5A, B, and 5C), the
95% CIs of model predictions encompassed the medians
of the measured data for 16 out of 24 experimental con-
ditions (eight sampling times and three different TB con-
centrations). Generally, our model predicted the plasma
E2 concentrations better dur i n gt h eT Be x p o s u r ep h a s e
than during the depuration phase. This is not surprising
s i n c ew eo n l yc a l i b r a t e dt h em o d e lw i t he x p e r i m e n t a l
data from a TB exposure [7]. In addition, it is interesting
to see that the measured plasma E2 concentrations
declined from the t = P48 to P192 hours for both control
FHMs and FHMs exposed to different concentrations of
TB. However, the model predictions showed a different
trend; that is, for control FHMs, the predicted plasma E2
concentrations remained relatively stable throughout the
experimental period (Figure 5A); for TB-exposed FHMs,
after the exposure, the plasma E2 concentrations
increased and recovered to concentrations seen in unex-
posed FHMs. Since the measured plasma E2 concentra-
tions decreased in both control FHMs and FHMs
exposed to TB, we suspect that there might be some
experimental factors that we have not accounted for in
the model during the depuration phase.
Figure 5D, E, and 5F compare model-predicted plasma
VTG concentrations with the measured data. The median
model predictions were within 0.2 to 3.6 fold of the mea-
sured median, and the 95% CIs of model predictions
encompassed all the measured medians at each sampling
time. These results show that the model worked well for
Figure 3 Comparison of model predictions with measured data
in unexposed female FHMs. n = 95. White boxes represent model
predictions, and grey boxes represent measured data [38]. The solid
line within the box marks the median; the boundary of the box
farthest from zero indicates the 75
th percentile; the boundary of the
box closest to zero indicates the 25
th percentile; the whisker (error
bar) farthest from zero marks the 90
th percentile; whisker (error bar)
closest to zero marks the 10
th percentile; the circle farthest from
zero marks the 95
th percentile; and the circle closest to zero marks
the 5
th percentile.
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Page 15 of 22predicting the plasma E2 and VTG concentrations in
female FHMs exposed to 0, 0.05, and 0.5 μgT B / Lf o r
eight days.
After being calibrated with the experimental data from
Ankley et al. [7], our model accurately predicted the
plasma E2, T, and VTG concentrations in adult female
FHMs exposed to TB. This was achieved by simulating
AR-related ligand-receptor binding processes, and by
assuming two gene regulation mechanisms: i) down regu-
lation of AR production by free androgens; and ii) down
regulation of LH production by bound AR. It is note-
worthy that the model was able to accurately fit not only
the calibration data (see Additional file 2), but also the
VTG and E2 data from independent studies by Garcia-
Reyero et al. [39] and Ekman et al. [40]. These results
indicate that our AR-based modelling framework is plau-
sible, and could be used in studies focused on regulatory
aspects of the AR on HPG function. In a recent study,
Shoemaker et al. [49] developed a computational model
to simulate more detailed biochemical reactions in the
FHM steroidogenic pathway. However, their model did
not incorporate any AR-related signalling pathways. As
AR plays an essential role for androgen responses and
subsequent regulation of steroidogenesis, our model
advances the work of Shoemaker et al. [49] by simulating
AR-related signalling pathways.
The calibration and evaluation results showed that the
model was able to predict the three reproductive end-
points from different studies with different experimental
conditions. Although the data sets used to calibrate and
validate the model were from studies with different
experimental designs and analytic methods, the model
accounted for the differences and predicted the end-
points well. For example, the calibration data were mea-
sured in FHMs exposed to TB for 21 days with a flow-
through water exposure design, and the plasma VTG
concentrations were measu r e db yap o l y c l o n a lF H M -
based ELISA [7]. In contrast, one validation data set was
from FHMs exposed to TB for 48 hours with a static
water exposure design, and plasma VTG concentrations
measured using a monoclonal carp-based ELISA [39],
while the other validation data set was from FHMs
exposed to TB for 8 days followed by an 8 day depuration
in a flow-through system, with plasma VTG concentra-
tions measured using the polyclonal FHM-based ELISA.
With the parameter set calibrated with the data from one
study, our model predicted plasma E2 and VTG concen-
trations comparable to the measurements from the other
two studies. This indicates that the model not only fit the
data empirically, but also captured major features of the
HPG axis in female FHMs exposed to TB. In addition,
the two model evaluations also supported the point by
Watanabe et al. [20] that the VTG measurements by a
polyclonal FHM-based ELISA and by a monoclonal carp-
based ELISA are consistent.
Predictions for plasma VTG concentrations in EE2-exposed
FHMs
Figure 6 compares model-predicted and measured
plasma VTG concentrations in female FHMs exposed to
Figure 4 Comparison of model predictions with measured data in female FHMs exposed to TB for 48 hours. n = 32. White circles
represent model predictions, and grey circles represent measured data [39]. Each circle represents one measurement in one fish. (A) plasma VTG
concentrations, and (B) plasma E2 concentrations. The x-axis represents TB concentrations in μg/L. Note: for panel B, at 0.5 μg TB/L, there are
only 3 measured data points.
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Page 16 of 22three different concentrations of EE2 for 21 days [42].
For the 0.5, 1.5 and 4.5 ng/L exposures, respectively, the
90%, 80%, and 50% CIs of model-predicted VTG con-
centrations encompassed the medians of the measured
data. This trend suggests that the model predicts the
endpoint better when the EE2 exposure concentration is
high and closer to the exposure concentrations used to
calibrate the model (i.e., 10 and 100 ng EE2/L). For
FHMs exposed to 4.5 ng EE2/L, the median of our
model predictions was around 2 times higher than the
measured data, and all measured data were within the
95% CIs of the model predictions. Considering that
Figure 5 Comparison of model predictions with measured data in female FHMs exposed to TB for eight days followed by an eight-
day depuration. n = 8 at each sampling time. White boxes represent model predictions, and grey boxes represent measured data [40]. The
solid line within the box marks the median; the boundary of the box farthest from zero indicates the 75
th percentile; the boundary of the box
closest to zero indicates the 25
th percentile. Because of the small data size (n = 8), the plots only show the 50% confidence intervals. (A) plasma
E2 concentrations in control FHMs, (B) plasma E2 concentrations in FHMs exposed to 0.05 μg TB/L, (C) plasma E2 concentrations in FHMs
exposed to 0.5 μg TB/L, (D) plasma VTG concentrations in control FHMs, (E) plasma VTG concentrations in FHMs exposed to 0.05 μg TB/L, (F)
plasma VTG concentrations in FHMs exposed to 0.5 μg TB/L. The x-axis represents time in hours. P24, P48, P96, and P192 represent 24, 48, 96,
and 192 hours post-exposure, respectively.
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Page 17 of 22exposure concentrations less than 10 ng EE2/L and
exposure durations longer than 8 days are an extrapola-
tion of the model, model predictions of plasma VTG
concentrations for the 21-day 4.5 ng EE2/L exposure
were a surprisingly good fit. The low exposure concen-
tration, longer time frame exposure is more environ-
mentally relevant because EE2 concentrations range
from 0.5 to 15 ng EE2/L in the aquatic environment
[50-53], and aquatic animals may be exposed to the che-
mical throughout their lifetime.
Additionally, we simulated plasma VTG concentrations
in FHMs exposed to 1.5 ng EE2/L for 21 days as reported
by Brian et al. [43]. In total, four control FHMs and four
FHMs exposed to EE2 were simulated. Brian et al. mea-
sured the VTG concentrations with a polyclonal carp
VTG ELISA, which uses polyclonal antibodies prepared
from carp VTG. In contrast, VTG data used to calibrate
the model were measured with a homologous FHM VTG
ELISA, which uses polyclonal antibodies prepared from
FHM VTG. Direct comparison of the two methods have
shown that measurements of FHM plasma VTG concen-
trations can differ by several orders of magnitude [54]. As
a result, instead of comparing the model predictions with
the measured data directly, we compared the relative
changes of plasma VTG concentrations. The results
showed that the range of model-predicted relative change
was 0.44 to 4.93, while the range of the measured data
relative change was 0.78 to 0.82, all within the range of
model predictions.
Predictions for reproductive endpoints in a mixture of TB
and EE2
In the next phase of our analysis, we predicted liver ER
concentration, brain AR concentration, and plasma E2,
T, VTG, and luteinizing hormone (LH) concentrations
in female FHMs exposed to 15 ng TB/L, 10 ng EE2/L,
a n dam i x t u r eo f1 5n gT B / La n d1 0n gE E 2/L for 48
hours, respectively. For all endpoints, there was a
change after the chemical exposure began followed by
a recovery to baseline values after the exposure ended.
In panels A, B, and C, after exposure to TB, the
plasma E2, T, and VTG concentrations followed a
trend consistent with the data used in the model cali-
bration and evaluation. After exposure to EE2,p l a s m a
E2 and T concentrations decreased more dramatically
than that produced by TB exposure. We did not find
any reports of plasma E2 or T concentrations in female
FHMs exposed to EE2. However, in female zebrafish, it
w a so b s e r v e dt h a tb o t hp l a s m aE 2 and T concentra-
tions decreased after exposure to 15 ng EE2/L for 48
hours [55], which agrees with our model predictions.
In addition, plasma VTG concentrations increased
after exposure to EE2, consistent with the data used to
calibrate and evaluate our model. Interestingly, after
exposure to a mixture of TB and EE2, our model pre-
dicted that the plasma E2 and T concentrations
decreased in an additive manner. In contrast, the
plasma VTG concentration increased and followed the
trend of an EE2 exposure.
In panels D, E, and F of Figure 7, we plotted liver
ER, brain AR, and plasma LH concentrations, respec-
tively, as a function of time under the three different
exposure conditions. Liver ER concentrations were
predicted to decrease slightly after exposure to TB,
and increase dramatically after exposure to EE2 and in
response to the mixture. Predicted liver ER concentra-
tions after EE2 exposure are consistent with the gene
expression data in female FHMs exposed to 10 ng
EE2/L [56]. Brain AR concentrations were predicted to
increase after exposure to TB and the mixture, and
decrease slightly after exposure to EE2.P l a s m aL H
concentrations were predicted to decrease after expo-
sure to TB and the mixture, and increase slightly after
exposure to EE2 (consistent with observations in tele-
osts exposed to EE2 [25]). To date, we do not have
published data to evaluate model-predicted effects for
am i x t u r eo fT Ba n dE E 2. In addition, three of the pre-
dicted endpoints (liver ER, brain AR, and plasma LH
concentrations) have not been measured in FHM at a
protein level because of experimental limitations.
However, the predictions can be used to generate
hypotheses and help explore possible mechanisms and
pathways, which might be tested in the future.
Figure 6 Comparison of model predictions with measured data
in female FHMs exposed to EE2. n = 28 at each sampling time.
White boxes represent model predictions, and grey boxes represent
measured data [42]. The x-axis represents EE2 concentrations in ng/
L. The solid line within the box marks the median; the boundary of
the box farthest from zero indicates the 75
th percentile; the
boundary of the box closest to zero indicates the 25
th percentile;
the whisker (error bar) farthest from zero marks the 90
th percentile;
whisker (error bar) closest to zero marks the 10
th percentile; the
circle farthest from zero marks the 95
th percentile; and the circle
closest to zero marks the 5
th percentile.
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The model represents the HPG axis in adult female
FHM robustly, and predicts plasma E2, T and VTG con-
centrations in female FHMs exposed to TB, EE2,o ra
mixture of TB and EE2. This model links environmental
estrogen and androgen exposure to changes in apical
reproductive endpoints, and serves as a foundation that
can be extended to simulate oocyte growth dynamics
and other aspects of reproduction. In this study, the
model predicted reproductive endpoints from indepen-
dent studies well. For more than 85% of the simulation
results, the 95% CIs of model predictions encompassed
the median of the experimental data. To further evaluate
the model’s predictive ability, more experimental data
are needed, especially for the endpoints in FHMs
exposed to a mixture of TB and EE2.
Important new features of this model include: (i) the
simulation of AR in multiple tissue compartments (i.e.,
brain, liver, and gonad); (ii) AR binding and its effects
upon the HPG axis; and (iii) free androgen effects on
brain AR concentration. As a result, this model provides
a computational framework for endocrine responses of
EDCs functioning through both ER and AR.
The model can be used to generate hypotheses to
facilitate studies of endocrine responses in female
FHMs exposed to other estrogenic EDCs in addition to
EE2, or other androgenic EDCs in addition to TB. The
application can be achieved by defining chemical-speci-
fic parameters, such as partition coefficients (e.g.,
blood to water, or tissue to blood), and binding affi-
nities to ER and AR. Furthermore, the endpoints simu-
lated in this study (i.e. plasma E2,Ta n dV T G
concentrations) are important determinants affecting
egg production in FHMs. In the future, this model
could be linked to an oocyte growth dynamics model
developed by Li et al. (accepted). Linking these two
models would build a connection between EDC effects
at a molecular level with effects upon an organism,
and thus a population, which is an urgent need in eco-
logical risk assessment.
Additional material
Additional file 1: Differential equations used in the HPG axis model.
The file was created in Microsoft Office Word 2003. The file contains a list
of the differential equations used in the HPG axis model for female
fathead minnows.
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Page 19 of 22Additional file 2: U-shaped dose-response curves between TB water
exposure concentrations and plasma E2, T, and VTG concentrations
in adult female FHMs. The file was created in Microsoft Office Word
2003. The file contains three plots for the non-monotonic relationship
between TB water exposure concentrations and plasma E2, T, and VTG
concentrations in adult female FHMs [7].
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